![]() |
|
|
Vol. 29, Issue 12, 1539-1547, December 2001
Department of Pharmaceutical Sciences, Faculty of Pharmacy
(D.C., A.K.Y.F., K.S.P.) and Department of Pharmacology, Faculty of
Medicine (R.L., K.S.P.), University of Toronto, Toronto, Ontario,
Canada
Oral bioavailability is a consequence of intestinal absorption,
exsorption, and metabolism and is further modulated by the difference
in activities among segmental regions. The influence of these factors
on the net absorption of benzoic acid (BA), a substrate that is
metabolized to hippurate and is transported by the monocarboxylic acid
transporter 1, was studied in the recirculating, vascularly perfused,
rat small intestine preparation. Metabolism of BA was not observed for
both systemic and intraluminal injections into segments of varying
lengths. But, secretion of BA into lumen was noted. Absorption of BA
(0.166-3.68 µmol) introduced at the duodenal end for absorption by
the entire intestine was complete (>95% dose at 2 h) and
dose-independent, yielding similar absorption rate constants
(ka of 0.0464 min
1). The
extent of absorption remained high (92-96% dose) when BA was injected
into closed segments of shorter lengths (12 or 20 cm), suggesting a
large reserve length of the rat intestine. However, ka was higher for the jejunum (0.0519 and
0.0564 min
1, respectively, for the 12- and 20-cm
segments) and exceeded that for the duodenum (12-cm segment, 0.0442 min
1) and ileum (20-cm segment, 0.0380 min
1) at closed injection sites. The finding paralleled
the distribution of monocarboxylic acid transporter isoform 1 detected by Western blotting along the length of the small intestine.
Fits of the systemic and oral data (based on duodenal injection for
absorption by the whole intestine) to the traditional, physiological
model and to the segregated flow model (SFM) that describes partial intestinal flow to the enterocyte region showed a better fit with the
SFM even though metabolite data were absent.
This article has been cited by other articles:
![]() |
S. Liu, D. Tam, X. Chen, and K. S. Pang P-Glycoprotein and an Unstirred Water Layer Barring Digoxin Absorption in the Vascularly Perfused Rat Small Intestine Preparation: Induction Studies with Pregnenolone-16{alpha}-carbonitrile Drug Metab. Dispos., September 1, 2006; 34(9): 1468 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, F. Chen, S. Liu, H. Glaeser, P. A. Dawson, A. F. Hofmann, R. B. Kim, B. L. Shneider, and K. S. Pang Transactivation of Rat Apical Sodium-Dependent Bile Acid Transporter and Increased Bile Acid Transport by 1{alpha},25-Dihydroxyvitamin D3 via the Vitamin D Receptor Mol. Pharmacol., June 1, 2006; 69(6): 1913 - 1923. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Pang MODELING OF INTESTINAL DRUG ABSORPTION: ROLES OF TRANSPORTERS AND METABOLIC ENZYMES (FOR THE GILLETTE REVIEW SERIES) Drug Metab. Dispos., December 1, 2003; 31(12): 1507 - 1519. [Full Text] [PDF] |
||||
![]() |
D. Tam, R. G. Tirona, and K. S. Pang Segmental Intestinal Transporters and Metabolic Enzymes on Intestinal Drug Absorption Drug Metab. Dispos., April 1, 2003; 31(4): 373 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Schwab, L. Tao, M. Kang, L. Meng, and K. S. Pang Moment Analysis of Metabolic Heterogeneity: Conjugation of Benzoate with Glycine in Rat Liver Studied by Multiple Indicator Dilution Technique J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 279 - 289. [Abstract] [Full Text] |
||||